2023-05-12T10:26:37-05:00 2022-06-30 BDO USA LLP 100 PARK AVENUE NEW YORK NY 100175001 990 2021-07-01 954335088 Lymphoma Research Foundation % CAROL FLORES LYMP 2123492910 WALL ST PLAZA 88 PINE ST ste 2400 NEW YORK NY 10005 Meghan Gutierrez CEO 2123492910 2023-05-11 true Meghan Gutierrez 999009999 Paul Hammerschmidt P01384178 2128858000 3 2021 2023-04-26 12:10:37Z MEGHAN GUTIERREZ WALL ST PLAZA 88 PINE ST NEW YORK NY 10005 20001525 false X WWW.LYMPHOMA.ORG X 2001 NY TO ERADICATE LYMPHOMA AND SERVE THOSE TOUCHED BY THIS DISEASE. 18 18 34 20000 0 0 10361473 9913811 5533517 4596956 231486 154465 -22618 44695 16103858 14709927 2240100 5760500 0 0 3026792 3571099 0 0 1999944 2869739 3569296 8136631 12900895 7967227 1809032 31207101 35546178 4587960 7990127 26619141 27556051 X THE LYMPHOMA RESEARCH FOUNDATION'S (LRF) MISSION IS TO ERADICATE LYMPHOMA AND SERVE THOSE TOUCHED BY THIS DISEASE. LRF IS DEDICATED TO IDENTIFYING A CURE THROUGH AN INNOVATIVE RESEARCH PROGRAM AND TO HELPING MEMBERS OF THE LYMPHOMA COMMUNITY BY PROVIDING COMPREHENSIVE, DISEASE-SPECIFIC PROGRAMS AND SUPPORT SERVICES. LRF INVESTS MILLIONS OF DOLLARS EVERY YEAR TO COMBAT LYMPHOMA AND ASSIST THOSE WHOSE LIVES HAVE BEEN AFFECTED BY A LYMPHOMA DIAGNOSIS. LRF IS SUPPORTED BY MORE THAN 20,000 VOLUNTEERS WHO CONTRIBUTE THEIR TIME AND TALENTS TO FURTHER THE LRF MISSION AND SERVE THEIR LOCAL COMMUNITIES. LRF HAS EARNED THE TRUST OF INDIVIDUALS, PRIVATE FOUNDATIONS, PUBLIC COMPANIES, AND ORGANIZATIONS THAT FUND ITS WORK BY DEMONSTRATING A HISTORY OF CAREFUL AND PROVEN FINANCIAL STEWARDSHIP. false false 6669043 5725000 0 Research and Patient Aid - THE FOUNDATION IS COMMITTED TO FUNDING THE MOST ADVANCE PATIENT CARE AND IMPROVE PATIENT OUTCOMES. THROUGH ITS LYMPHOMA CONSORTIA, RESEARCH INITIATIVES, AND SCIENTIFIC WORKSHOPS, LRF MOBILIZES THE RESEARCH COMMUNITY TO SPEED THE DEVELOPMENT AND USE OF NEW TREATMENTS. 2188429 35500 4596956 Educational Programs and Patient Services - LRF PROVIDES A COMPREHENSIVE SERIES OF PROGRAMS AND SERVICES FOR THE LYMPHOMA COMMUNITY INCLUDING, BUT NOT LIMITED TO, CONTINUING MEDICAL EDUCATION, CLINICAL TRIALS INFORMATION SERVICES, DISEASE SPECIFIC PUBLICATIONS AND WEBSITES, IN-PERSON PATIENT WORKSHOPS AND EDUCATIONAL FORUMS, LYMPHOMA HELPLINE, ONLINE SERVICES, PATIENT AID GRANTS, TELECONFERENCES AND WEBCASTS/PODCASTS, WITH A VOLUNTEER COMMUNITY NETWORK. 1254573 0 0 Communications and Advocacy - THROUGH STRATEGIC COMMUNICATIONS, LRF SEEKS TO RAISE AWARENESS OF LYMPHOMA AND THE NEEDS OF PEOPLE WITH LYMPHOMA. DIGITAL PROGRAMMING ENSURES ACCESS TO ACCURATE INFORMATION AND DIGITAL PROGRAMS INCLUDING MOBILE APPS. LRF'S ADVOCACY PROGRAM ENABLES VOLUNTEERS TO REPRESENT THE NEEDS OF PEOPLE WITH LYMPHOMA BY SUPPORTING PUBLIC POLICIES WHICH SEEK TO INCREASE FEDERAL FUNDING FOR LYMPHOMA RESEARCH AND ENSURE ACCESS TO HIGH QUALITY CANCER CARE 10112045 true true false true false false false false false false true false false false false true false true false false true true false false true false false true true true false false false false false false false false true false false false false true true false false false true 34 0 true 34 true false false false false false true true false false false false false false X 18 18 false false false false false false false true true false false true true true true true true true false false AL AR CA FL GA HI IL KS KY MD MA MI MN MS MO NV NH NJ NM NY NC OR PA RI SC TN UT VA WV WI X X X CAROL FLORES 2123492910 WALL ST PLAZA 88 PINE ST STE 2400 NEW YORK NY 10005 X MEGHAN GUTIERREZ CHIEF EXECUTIVE OFFICER 35.0 0.0 X 318291 0 10282 CAROLINA FLORES SENIOR DIRECTOR OF FINANCE 35.0 0.0 X 179168 0 17094 SARAH QUINLAN SENIOR DIRECTOR, PROGRAM 35.0 0.0 X 164413 0 8077 KINYA HARTE DIRECTOR, COMM. & MARKETING 35.0 0.0 X 130800 0 6516 Victor Gonzalez Senior Director, Patient Prog. 35.0 0.0 X 109148 0 6722 Kathryn LeBoeuf Director, Maj.& Planned Giving 35.0 0.0 X 112431 0 3331 William White Director of Peer to Peer Fund 35.0 0.0 X 101518 0 5812 STEVEN EICHBERG board chair 5.0 0.0 X X 0 0 0 JEFF BLOCK VICE CHAIR AND TREASURER 2.0 0.0 X X 0 0 0 KIM METCALF VICE CHAIR 2.0 0.0 X X 0 0 0 LEIGH OLSON SECRETARY 2.0 0.0 X X 0 0 0 MICHAEL AKINYELE BOARD MEMBER 1.0 0.0 X 0 0 0 MICHAEL FROY BOARD MEMBER 1.0 0.0 X 0 0 0 Harriet Greenberg BOARD MEMBER, EFF. 6/21 1.0 0.0 X 0 0 0 ROBERT MCAULEY BOARD MEMBER 1.0 0.0 X 0 0 0 JOHN A NELSON BOARD MEMBER 1.0 0.0 X 0 0 0 SCOTT PANSKY BOARD MEMBER 1.0 0.0 X 0 0 0 Diane Parks BOARD MEMBER, EFF. 10/21 1.0 0.0 X 0 0 0 Joel Pollick BOARD MEMBER, EFF. 6/21 1.0 0.0 X 0 0 0 Kevin Shea BOARD MEMBER, EFF. 10/21 1.0 0.0 X 0 0 0 John P Leonard MD Past Chair, Scientific Advisor 1.0 0.0 X 0 0 0 Steven J Prince PAST CHAIR 1.0 0.0 X 0 0 0 Sonali M Smith MD eff721 Chair, Scientifc Advisory Boar 1.0 0.0 X 0 0 0 Morton Coleman MD Past Chair Scientific Advisory 1.0 0.0 X 0 0 0 MICHAEL WERNER IMMEDIATE PAST CHAIR 1.0 0.0 X 0 0 0 1115769 0 57834 7 false true false Med Communications Inc 5100 POPLAR AVE SUITE 450 MEMPHIS TN 38137 communications 278079 Allison Partners LLC ONE WORLD TRADE CENTER 65TH FLOOR NEW YORK NY 10007 public relations 247611 Build Consulting LLC PO Box 223444 CHANTILLY VA 20153 IT Consulting 194666 Harborside Hotel LLC dba Hyatt Rege 2 Exchange Plaza JERSY CITY NJ 07302 VENUE & CATERING 193247 Blackbaud PO Box 844827 BOSTON MA 022844827 SOFTWARE 180579 8 15016 1903845 486300 7508650 131511 9913811 EDUCATION PROGRAMS & PATIENT SERVICES 812900 4596956 4596956 4596956 153520 153520 0 22595 22595 0 0 0 5234543 5233598 945 945 945 58000 1903845 58000 0 0 0 0 0 0 MISCELLANEOUS REVENUE 900099 22100 22100 22100 14709927 4596956 0 199160 4870000 4870000 35500 35500 855000 855000 0 513790 280813 66369 166608 0 2260446 1243407 279316 737723 78822 34628 23649 20545 411350 180714 123418 107218 306691 134735 92017 79939 0 14697 14697 54696 54696 0 0 0 1076131 849241 22649 204241 459457 442157 277 17023 338198 228085 14290 95823 60021 43286 5498 11237 0 381120 209643 47094 124383 188912 154792 1765 32355 0 645701 465741 1664 178296 0 0 65729 36156 8122 21451 31204 17164 3856 10184 DUES & SUBSCRIPTIONS 297252 183722 21902 91628 PROCESSING FEES 124805 28513 2973 93319 REPAIRS & MAINTENANCE 13475 7347 1769 4359 LICENSES & PERMITS 11296 4799 2885 3612 -193398 -193398 12900895 10112045 788906 1999944 5490247 9111263 20746950 23159618 0 488721 4579682 2401505 0 0 0 0 0 0 0 0 235074 285347 382265 282541 155148 99724 0 0 0 0 0 0 0 0 0 0 31207101 35546178 623001 1052864 3199409 6741890 279250 195373 0 0 0 0 0 0 0 0 486300 0 0 0 4587960 7990127 X 5562400 5715532 21056741 21840519 26619141 27556051 31207101 35546178 1809032 -872122 X false true X true false X 7229093 7623538 9778478 10361473 9913811 44906393 0 0 7229093 7623538 9778478 10361473 9913811 44906393 13034706 31871687 116297 227922 312354 234178 176115 1066866 0 0 0 0 0 15189 14788 2356 39700 22100 94133 46067392 20605854 0.69185 0.77120 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false true false false false true 30000 false true 107862 137862 false PART II-B, LINE 1: CONTACT WITH LEGISLATORS, THEIR STAFF, GOVERNMENT OFFICIALS, LEGISLATIVE BODIES, AND ASSOCIATED GRASSROOTS ACTIVITIES TO PRESENT ISSUES OF CONCERN RELATED TO LYMPHOMA. 113640 59193 54447 200427 190508 9919 68198 32840 35358 99724 0 0 X 14982264 -872122 1144459 272337 14709927 14709927 14045354 1144459 1144459 12900895 12900895 PART X, LINE 2: The Foundation follows U.S. GAAP, which requires accounting for uncertainty in tax positions taken or expected to be taken in a tax return, including issues relating to financial statement recognition and measurement. U.S. GAAP provides that the tax effects from an uncertain tax position can only be recognized in the consolidated financial statements if the position is more likely than not to be sustained if the position were to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard to the likelihood that the tax position may be challenged. The Foundation is incorporated in the state of New York and is exempt from federal income tax under IRC section 501(c)(3), though it is subject to tax on income unrelated to its exempt purpose, unless that income is otherwise excluded by the IRC. The Organization has no unrelated income associated with its exempt purpose. The Foundation has processes presently in place to ensure the maintenance of its tax-exempt status, to identify and report unrelated income, to determine its filing and tax obligations in jurisdictions for which nexus was established, and to identify and evaluate other matters that may be considered tax positions. The Foundation has determined that there are no material uncertain tax positions that require recognition or disclosure in the consolidated financial statements. As of June 30, 2022, the Foundation was not subject to an examination by a taxing authority. true North America Grantmaking 855000 855000 855000 North America Follicular 750000 CHECK North America FELLOWSHIP 105000 CHECK 2 false false false false false false ANNUAL GALA 793703 793703 WALKS 349041 349041 3 819101 761101 58000 58000 1961845 1903845 58000 58000 58000 true MAYO CLINIC PO Box 860334 Minneapolis MN 55486 416011702 501(C)(3) 750000 Follicular Washington University in StLouis Campus Box 1035 St Louis MO 63112 430653611 501(C)(3) 750000 Follicular Massachusetts General Hospital PO Box 414876 Boston MA 02241 042697983 501(C)(3) 750000 Follicular Memorial Sloan Kettering Cancer Center PO Box 27106 New York NY 10087 131924236 501(C)(3) 750000 Follicular Miller School of Medicine of the Univ0 of Miami PO Box 405803 Atlanta GA 30384 590624458 501(C)(3) 225000 CDA Sloan Kettering Institute for Cancer Research PO Box 27106 New York NY 10087 131624182 501(C)(3) 450000 CDA The University of Utah 201 St Presidents Circle Rm 406 Salt Lake City UT 84112 876000525 501(C)(3) 225000 CDA University of Pennsylvania PO Box 785541 Philadelphia PA 19178 231352685 501(C)(3) 210000 Fellowship The Brigham and Womens Hospital Inc PO Box 3149 Boston MA 02241 042312909 501(C)(3) 105000 Fellowship University of Texas MD Anderson Cancer Center PO Box 4266 Houston TX 77210 746001118 105000 Fellowship Washington University in StLouis Campus Box 1034 St Louis MO 63112 430653611 501(C)(3) 105000 Fellowship Dana-Farber Cancer Institute 450 Brookline Avenue BP437 Boston MA 02215 042263040 501(C)(3) 105000 Fellowship The Regents of the University of California 490 Illinois Street 4th Floor San Francisco CA 94143 946036493 501(C)(3) 105000 Fellowship Columbia University in the City of New York PO Box 29789 New York NY 100879789 135598093 501(C)(3) 105000 Fellowship University of Texas MD Anderson Cancer Center PO Box 4266 Houston TX 77210 746001118 30000 Mentoring Weill Medical College of Cornell University 575 Lexington Avenue 9th Floor New York NY 10022 131623978 20000 Mentoring Memorial Sloan Kettering Cancer Center (MSK) PO Box 27106 New York NY 10087 131924236 501(C)(3) 20000 Mentoring New York University Grossman School of Medicine PO Box 415026 Boston MA 10016 135562308 501(C)(3) 10000 Mentoring Columbia University in the City of New York PO Box 29789 New York NY 10087 135598093 501(C)(3) 10000 Mentoring The Regents of the University of California (Irvin 120 Theory Suite 200 Irvine CA 92697 952226406 501(C)(3) 10000 Mentoring The University of Utah 201 S Presidents Circle Rm 406 P Salt Lake City UT 841129023 876000525 501(C)(3) 10000 Mentoring Dana-Farber Cancer Institute 450 Brookline Avenue BP437 Boston MA 022155450 042263040 501(C)(3) 10000 Mentoring The University of Chicago 6054 S Drexel Ave Suite 300 Chicago IL 60637 362177139 501(C)(3) 10000 Mentoring 20 3 Patient Aid Grant 355 35500 PART I, LINE 2: LRF'S EXPERT SCIENTIFIC ADVISORY BOARD (SAB) CONDUCTS PEER REVIEW FOR ALL GRANT PROPOSALS AND RECOMMENDS THE HIGHEST-SCORING PROPOSALS TO THE LRF BOARD OF DIRECTORS FOR FUNDING. THE BOARD OF DIRECTORS THEN CONSIDERS AND APPROVES THE GRANTS WHICH ARE TO BE FUNDED. ONCE A GRANT IS APPROVED AND ACCEPTED BY THE GRANTEE, THE GRANTEE WILL BEGIN TO RECEIVE INSTALLMENTS BASED UPON THE PAYMENT SCHEDULE AS DICTATED IN THE GRANT CONTRACT. THE SAB AND LRF'S RESEARCH DEPARTMENT ANNUALLY REVIEW EACH GRANTEE'S PROGRESS AGAINST DELIVERABLES AND APPROVES THE CONTINUATION OF GRANT PAYMENTS. PART III, LINE 1: LRF PROVIDES FINANCIAL ASSISTANCE TO LYMPHOMA PATIENTS WHO STRUGGLE TO PAY FOR EXPENSES RELATED TO THEIR LYMPHOMA TREATMENTS, SUCH AS MEDICAL BILLS AND TRANSPORTATION COSTS. LRF SUPPORT SERVICES STAFF REVIEWS THE APPLICATIONS, VALIDATES APPLICATION CRITERIA AND SUBMITS APPLICATIONS FOR PAYMENT APPROVAL TO DEPARTMENT LEADERSHIP. X X X false false false false false false false true false MEGHAN GUTIERREZ CHIEF EXECUTIVE OFFICER 288291 0 30000 0 0 0 10127 0 155 0 328573 0 0 0 CAROLINA FLORES SENIOR DIRECTOR OF FINANCE 164168 0 15000 0 0 0 6204 0 10890 0 196262 0 0 0 SARAH QUINLAN SENIOR DIRECTOR, PROGRAM 154413 0 10000 0 0 0 5417 0 2660 0 172490 0 0 0 PART I, LINE 7: SCHEDULE J, PART II, COLUMN (B)(II) REPORTS DISCRETIONARY INCENTIVE AMOUNTS THAT WERE APPROVED BY THE BOARD BASED UPON PERFORMANCE. X 14 131511 MARKET QUOTATION false true false PART I, COLUMN B: NUMERICAL DATA HERE REPRESENTS THE TOTAL NUMBER OF CONTRIBUTIONS RECEIVED. FORM 990, PART VI, SECTION B, LINE 11B: FORM 990 WAS PREPARED BY A NATIONAL ACCOUNTING FIRM IN CONJUNCTION WITH THE ORGANIZATION'S FINANCIAL DEPARTMENT. THE FORM 990 WAS REVIEWED IN DETAIL BY MANAGEMENT. AFTER REVIEW A FINAL DRAFT WAS PRESENTED TO THE AUDIT COMMITTEE AND FULL BOARD OF DIRECTORS FOR REVIEW AND COMMENT PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C: THE CONFLICT OF INTEREST POLICY IS REVIEWED AND SIGNED ANNUALLY BY BOARD MEMBERS, OFFICERS AND STAFF. FORM 990, PART VI, SECTION B, LINE 15A: THE ORGANIZATION SETS COMPENSATION IN A MANNER GIVING RISE TO A REBUTTABLE PRESUMPTION THAT THE COMPENSATION IS REASONABLE UNDER STANDARDS SET FORTH IN TREASURY REGULATIONS SECTION 53.4958-6. SALARIES OF THE SENIOR STAFF, INCLUDING THE CEO, ARE DETERMINED BASED UPON MARKET INFORMATION COMPARABLE TO THE POSITION IN OTHER NON-PROFIT ORGANIZATIONS. THE CEO'S COMPENSATION IS APPROVED BY THE EXECUTIVE COMMITTEE (EC), WHICH HAS BEEN DULY AUTHORIZED BY THE BOARD AND CONSISTS OF INDEPENDENT MEMBERS, AND THE APPROVAL IS DOCUMENTED CONTEMPORANEOUSLY IN THE EC MINUTES. FORM 990, PART VI, SECTION C, LINE 19: THE ORGANIZATION'S GOVERNING DOCUMENTS, FINANCIAL STATEMENTS AND THE CONFLICT OF INTEREST POLICY ARE AVAILABLE TO THE PUBLIC UPON REQUEST. THE ORGANIZATION ALSO MAKES ITS FINANCIAL STATEMENTS AVAILABLE THEIR WEBSITE. LRF RESEARCH INC WALL ST PLAZA 88 PINE ST STE 24 NEW YORK NY 10005 611844536 INVESTMENT FUND NY LRF C CORP 0 0 1.00000 true false false false false false false false false false false false false false false false false false false false